<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/421B4793-37B1-4BD6-AAD9-8B6C240ED8C9"><gtr:id>421B4793-37B1-4BD6-AAD9-8B6C240ED8C9</gtr:id><gtr:name>Duke University</gtr:name><gtr:address><gtr:line1>Edmund T Pratt</gtr:line1><gtr:postCode>27708-0300</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2294A225-2437-4CA3-94DA-50340C98A54E"><gtr:id>2294A225-2437-4CA3-94DA-50340C98A54E</gtr:id><gtr:name>Duke University Medical Centre</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Sch of Geography, Earth &amp; Env Sciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/421B4793-37B1-4BD6-AAD9-8B6C240ED8C9"><gtr:id>421B4793-37B1-4BD6-AAD9-8B6C240ED8C9</gtr:id><gtr:name>Duke University</gtr:name><gtr:address><gtr:line1>Edmund T Pratt</gtr:line1><gtr:postCode>27708-0300</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75E77BF3-29B4-4699-9CD9-223230E8A463"><gtr:id>75E77BF3-29B4-4699-9CD9-223230E8A463</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2294A225-2437-4CA3-94DA-50340C98A54E"><gtr:id>2294A225-2437-4CA3-94DA-50340C98A54E</gtr:id><gtr:name>Duke University Medical Centre</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0D055105-4149-452C-BEF6-C180B163A684"><gtr:id>0D055105-4149-452C-BEF6-C180B163A684</gtr:id><gtr:firstName>Ye</gtr:firstName><gtr:otherNames>Htun</gtr:otherNames><gtr:surname>Oo</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501638"><gtr:id>56AD6F2D-9A2E-4BE3-B71A-CD236CB35B8B</gtr:id><gtr:title>The molecular basis of regulatory T cell recruitment to the inflamed liver</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0501638</gtr:grantReference><gtr:abstractText>Immune system of body recognise and attack invading non-self antigen at the same time recongnize the self antigen. Most chronic liver diseases occur as a consequence of the recruitment from blood of white blood cells called T cells which are designed to fight infection but as a side-effect also cause tissue damage. In recent years a subset of T cells called regulatory cells (Treg) has been described which suppresses tissue damage caused by other T cells. These cells evolved to prevent collateral damage during immune responses to infections but recent evidence suggests they are important in chronic inflammation, transplant rejection, autoimmune diseases and tumor immune response. Consistent with this, I have detected increased numbers of Treg in patients with chronic inflammatory liver diseases. I hypothesise that particular Treg will be recruited to the liver during inflammation and that specific molecules will control this process. I plan to test this hypothesis using a combined approach in which the homing behaviour of these cells in studied in human systems in vitro as well as by transferring cells in vivo. These studies will be among the first to investigate how Treg are recruited form the blood into sites of liver inflammation and may suggest new treatments for inflammatory liver diseases in which the number of local Treg within the tissue is manipulated in favour of resolution of inflammation.</gtr:abstractText><gtr:technicalSummary>Autoimmune liver diseases develop due to breakdown in immunological tolerance of self-antigens. Suppression of self-reactive T cells by CD4+CD25+ regulatory T cells (Treg) is essential for self-tolerance but little is known about how these cells enter tissues. I have detected intrahepatic Treg in autoimmune liver disease and shown they express high levels of the chemokine receptor CXCR3 which we have shown to be involved in lymphocyte recruitment to the liver. I hypothesise that activation of Treg in hepatic lymphoid tissues results in the loss of lymph node homing receptors and the acquisition of CXCR3 and other receptors that promote entry to inflamed liver where they suppress inflammation. To test this hypothesis I will carry out the following studies
Study 1 The expression of homing receptors on intrahepatic Treg will be determined using confocal microscopy of liver tissue and detailed flow cytometry of Treg isolated from normal and inflamed liver tissue. Intrahepatic Treg will be compared with those isolated from lymph node and skin and regulatory function confirmed using allogeneic suppression assays.
Study 2 To determine how Treg enter liver tissue during recruitment from blood I will use tissue and cell-based adhesion assays to study Treg adhesion to human hepatic endothelium. I will inhibit the homing receptors defined in study 1 to determine which molecules are involved.
Study 3. Do different populations of Treg undergo tissue-specific homing in vivo? Although in vitro models will provide unique information about Treg recruitment via human hepatic endothelium I also need to investigate these processes in vivo. Adoptive transfer experiments in a murine hepatitis model will be used to compare tissue-specific homing of CD4+CD25- (non-regulatory) T cells with CD4+CD25high Treg. In addition by sorting Treg based on expression of CXCR3 and other homing receptors I will be able to determine which receptors specifically promote Treg recruitment to inflamed liver. Finally I will use intravital microscopy to determine the molecular interactions involved in Treg recruitment via the hepatic vasculature.
These studies will be the first to define the molecular regulation of Treg recruitment to the liver. In addition they may suggest strategies in which therapeutic Treg are generated with a tissue-homing phenotype for specific delivery to the liver in patients with autoimmune liver disease.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-02</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>202010</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Duke University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Hepatology</gtr:department><gtr:description>Osteopontin promote fiborsis progression in NAFLD</gtr:description><gtr:id>B75791B2-FC30-4405-8058-3365C993E076</gtr:id><gtr:impact>Osteopontin is induced by Hedgehog Pathway Activation and Promotes Fibrosis Progression in Nonalcoholic Steatohepatitis. Hepatology Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in non-alcoholic steatohepatitis. Hepatology 2010 (in press DOI: 10.1002/hep.23998).</gtr:impact><gtr:outcomeId>h7yBzfVNfGo-1</gtr:outcomeId><gtr:piContribution>Immunohistochemical staining of Osteopontin in human liver tissue</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Peter Medawar Building for Pathogen Research</gtr:department><gtr:description>HCV vaccination</gtr:description><gtr:id>2337AF2D-4E23-44E9-AC8F-5F29FC47B572</gtr:id><gtr:impact>Still in recruitment. Five patients from Birmingham vaccinated</gtr:impact><gtr:outcomeId>cUmB6Bppdho-1</gtr:outcomeId><gtr:piContribution>Second UK centre for HCV Therepeutic vaccination in Genotype 1 patients</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Duke University Medical Centre</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Accumulation of NKT cells in Progressive Non Alcoholic Steato Hepatitis</gtr:description><gtr:id>48F08870-2343-46E7-B96A-6ABDAB899A44</gtr:id><gtr:impact>Accumulation of NKT cells in progressive NASH,. (Hepatology. 2010 Jun;51(6):1998-2007)</gtr:impact><gtr:outcomeId>8C195E10E06-1</gtr:outcomeId><gtr:partnerContribution>Understanding of NKT in human liver disease</gtr:partnerContribution><gtr:piContribution>Phenotyping of Human NKT population in normal and diseaase</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Peter Medawar Building for Pathogen Research</gtr:department><gtr:description>CD8aa and IL-22 cells in HCV</gtr:description><gtr:id>3A11B47F-6EF5-493A-8281-ABAD53B7EFD1</gtr:id><gtr:impact>? Lucy J Walker, Yuhoi H Kang, Matthew O Smith, Hannah Tharmalingham, Ye Htun Oo, Thomas J Scriba, Willem A Hanekom, Georg M Lauer, David H Adams , Eleanor Barnes, Paul Klenerman. Human CD8aaT cells are a CD161++ subset with distinct functional characteristics. (submitted to Gastroenterology)
? Yu-Hoi Kang, Eva Billerbeck, Vicki Fleming, Stefanie Grafmueller, Lucy Walker, Chris B. Willberg, Eleanor J. Barnes, Anisha Bhagwanani, Ye Htun Oo, Hubert E Blum, David H. Adams, Robert Thimme, Paul Klenerman. Recruitment of IL-22 secreting CD4+ T cells to the liver in hepatitis C. (submitted to Hepatology)</gtr:impact><gtr:outcomeId>beChUakD9Bu-1</gtr:outcomeId><gtr:piContribution>Liver infiltrating lymphocytes isolation and phenotyping</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Babraham Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Th17 and AHR ligands</gtr:description><gtr:id>5A0EA4E9-7C7A-49C9-A5CE-6E2E3B64E94D</gtr:id><gtr:impact>Not started yet</gtr:impact><gtr:outcomeId>ZJXFDMXihqt-1</gtr:outcomeId><gtr:piContribution>Plan to go across to Institute to explore AhR ligands in liver</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Peter Medawar Building for Pathogen Research</gtr:department><gtr:description>Th17 and Tc17 in Human Hepatitis C infection</gtr:description><gtr:id>2F5A5ED0-014F-493E-ABD7-8A1B430EEAEF</gtr:id><gtr:impact>Analysis of CD161 expression on human CD8+ T cells defines a functional subset with tissue-homing properties; (Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3006-11)</gtr:impact><gtr:outcomeId>093CF43D799-1</gtr:outcomeId><gtr:partnerContribution>Understanding of IL-17 secreting lymphocytes in human hepatitis C liver</gtr:partnerContribution><gtr:piContribution>Phenotyping of freshly isolated Liver infiltrating lymphocytes</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School Visit</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F7C5C716-3B3F-411A-8CD8-756D8B402FDF</gtr:id><gtr:impact>Liver Transplantation ethics to grammer school students

Spread message on important of liver disease, transplantion and liver research</gtr:impact><gtr:outcomeId>htEzMcn72xj</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MAIR conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>57839598-F964-4212-8C3E-A4E52F5736F9</gtr:id><gtr:impact>Poster presentation on human Treg work

collaboration</gtr:impact><gtr:outcomeId>0BAB7E9FF9B</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Association of Study of Liver Disease Annual Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FA88EC98-5E07-40CF-979E-FF02B3188535</gtr:id><gtr:impact>Poster presentation at BASL meeting

Collaboration and understanding the impact of therapeutic potential for Regulatory T cells</gtr:impact><gtr:outcomeId>7EEB61EC1E0</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Gordon Immunology Conference</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A59B356C-B651-40A6-85F8-07169728731B</gtr:id><gtr:impact>Human Liver Infiltraing Regulator T cells

Collboration</gtr:impact><gtr:outcomeId>FD67D3D505D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>UK Adhesion Society</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DE2DEA8D-CD88-4AC8-9A97-28377231BAC5</gtr:id><gtr:impact>Oral presentation on Regularoty T cells role in human liver inflammation

Collaboration</gtr:impact><gtr:outcomeId>FFF6FF50375</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical Student Teaching on Immune Tolerance 2006,2007,2008,2009</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>C891B70A-6F98-4B2D-9FC1-5B297748DECF</gtr:id><gtr:impact>Part of Medical Student's teaching on Immunology, Autoimmune hepatitis and role of Regulatory T cells

Student's understanding of Immunological tolerance and consequence of brakdown in toleranc</gtr:impact><gtr:outcomeId>4DC53CD8EA1</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>EASL Immunology Meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EFFD4035-885C-4889-B0EE-DC83372CC1B9</gtr:id><gtr:impact>Phenotype and recruitment of Regulatory T cells in inflamed human liver

Collaboration, Learning new methodolgy</gtr:impact><gtr:outcomeId>4CAE507DA7F</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Association of Physician Annual Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7C879E0F-A173-4CF9-BB32-84575C8DE060</gtr:id><gtr:impact>Oral presentation on Distinct role of Regulatory T cells in inflamed human liver

Clinical cell based therapy potentail</gtr:impact><gtr:outcomeId>D95DA613BDF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Medical Research Society Annual Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>914554A7-9A19-4A78-B6DB-94E1B5791D06</gtr:id><gtr:impact>Poster presentation on human liver infiltrating Treg

Collaboration</gtr:impact><gtr:outcomeId>DCF7FC43526</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Sceince Festival to Public in Westmidlands</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>047967C5-E91A-4F32-B781-F18889CFA357</gtr:id><gtr:impact>Disseminate information to public on HCV vaccination work which is now being carried out in collaboration with Oxford

Awareness of public to liver disease</gtr:impact><gtr:outcomeId>dkm1ge9VN8v</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>American Association of Study of Liver Disease Annual Meeting</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>FD5A4849-2D3B-4EB8-89E6-082B650E091E</gtr:id><gtr:impact>Oral Presentation in 2008 on Regulatory T cell work Presendential Plenary Presentation in 2009 on Th17 work

Collaboration</gtr:impact><gtr:outcomeId>66F6132365D</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>86000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>IL-17 secreting cells in human liver</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Novartis</gtr:fundingOrg><gtr:id>1C753175-48EA-4D16-BC4A-26E49D19B52D</gtr:id><gtr:outcomeId>67CFDA7C51A0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2008-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BA6892B6-D278-4074-BFAB-8BF58818B2F4</gtr:id><gtr:title>Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>RLo1VCvEDRt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A31A499-CF6D-4468-AC59-DB2B07AAF56C</gtr:id><gtr:title>Tacrolimus and cyclosporin doses and blood levels in hepatitis C and alcoholic liver disease patients after liver transplantation.</gtr:title><gtr:parentPublicationTitle>Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1527-6465</gtr:issn><gtr:outcomeId>A14C492CB1E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20569C99-3F1F-479A-8B71-4C5C8CB4C420</gtr:id><gtr:title>Recurrence of nonviral diseases.</gtr:title><gtr:parentPublicationTitle>Clinics in liver disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1089-3261</gtr:issn><gtr:outcomeId>326CD9CDF41</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BFCFDA3-D375-440D-B3BE-38DE103BAD53</gtr:id><gtr:title>Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2ac724aa0f3497723528e917e16d0a1"><gtr:id>a2ac724aa0f3497723528e917e16d0a1</gtr:id><gtr:otherNames>Syn WK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>VRk988VZu7s</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3EB3431E-8831-4AE0-ADD4-50C2B5B3D8D9</gtr:id><gtr:title>Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of na&amp;iuml;ve patients with a partial virological response.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d5b8a8d3059030bee34a22cfc0ab374"><gtr:id>7d5b8a8d3059030bee34a22cfc0ab374</gtr:id><gtr:otherNames>Zoutendijk R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>CSWzavYE3TS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAD7CA1C-EA6E-4563-A55F-287ADED1AA6E</gtr:id><gtr:title>Symptomatic portal biliopathy: a single centre experience from the UK.</gtr:title><gtr:parentPublicationTitle>European journal of gastroenterology &amp; hepatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0954-691X</gtr:issn><gtr:outcomeId>F7116AC57C0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F341BE2B-85B6-40E9-9EF3-0D4159E8DE1B</gtr:id><gtr:title>Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd20de4d5c14af8cc708d7b67c01f07e"><gtr:id>bd20de4d5c14af8cc708d7b67c01f07e</gtr:id><gtr:otherNames>Shetty S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>kW3XeKkFRrd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C76C739F-0C2E-4C85-BB09-EE0D64C233F0</gtr:id><gtr:title>The role of chemokines in the recruitment of lymphocytes to the liver.</gtr:title><gtr:parentPublicationTitle>Digestive diseases (Basel, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0257-2753</gtr:issn><gtr:outcomeId>USNEQtT7mAF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B11383BF-57DC-472D-BD41-A61C157962B0</gtr:id><gtr:title>Supporting evidence for natural killer T cell accumulation in progressive nonalcoholic fatty liver disease?</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2ac724aa0f3497723528e917e16d0a1"><gtr:id>a2ac724aa0f3497723528e917e16d0a1</gtr:id><gtr:otherNames>Syn WK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>QYH986cMjPt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02590DC8-DC3D-471B-B818-AE902E6BF482</gtr:id><gtr:title>Patterns of bruising in preschool children with inherited bleeding disorders: a longitudinal study.</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/31de6c96c33b3ef1fa7060e6041e8f53"><gtr:id>31de6c96c33b3ef1fa7060e6041e8f53</gtr:id><gtr:otherNames>Collins PW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-9888</gtr:issn><gtr:outcomeId>585d3ad2a5f8a5.83237711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29398223-21FA-49D1-85F1-778917D05703</gtr:id><gtr:title>Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.</gtr:title><gtr:parentPublicationTitle>Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27ace1dad66fd838ac38227513452fd4"><gtr:id>27ace1dad66fd838ac38227513452fd4</gtr:id><gtr:otherNames>Da-Silva N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1590-8658</gtr:issn><gtr:outcomeId>tkNHjLKo4gV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3473362B-BCD3-4D3D-8FED-C7686ED63DF3</gtr:id><gtr:title>The role of chemokines in the recruitment of lymphocytes to the liver.</gtr:title><gtr:parentPublicationTitle>Journal of autoimmunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0896-8411</gtr:issn><gtr:outcomeId>32EF3F95485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1999A7EF-AEA6-425F-AC94-BA456EEAA611</gtr:id><gtr:title>Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/15677618d190f121dd682fd99401149d"><gtr:id>15677618d190f121dd682fd99401149d</gtr:id><gtr:otherNames>Billerbeck E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>oFE8ZSTSyza</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E18EEFB8-F952-4EFE-AB3B-6E47E4119D94</gtr:id><gtr:title>Mycophenolate mofetil as second line therapy in autoimmune hepatitis?</gtr:title><gtr:parentPublicationTitle>The American journal of gastroenterology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d57d5b9a038820db0bcbbd6e30bdb4c4"><gtr:id>d57d5b9a038820db0bcbbd6e30bdb4c4</gtr:id><gtr:otherNames>Hennes EM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0002-9270</gtr:issn><gtr:outcomeId>8AB5DF3B083</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBFB1F14-912F-4FD9-8924-BE3B6F5517DB</gtr:id><gtr:title>Human MAIT and CD8aa cells develop from a pool of type-17 precommitted CD8+ T cells.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01e010a90f68a03e6f502ca741eaf42f"><gtr:id>01e010a90f68a03e6f502ca741eaf42f</gtr:id><gtr:otherNames>Walker LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>LqsGJ23aESP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C42D0B79-D4FA-4068-83C4-3983BC6B9209</gtr:id><gtr:title>Autoimmune hepatitis: new paradigms in the pathogenesis, diagnosis, and management.</gtr:title><gtr:parentPublicationTitle>Hepatology international</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1936-0533</gtr:issn><gtr:outcomeId>KZeeNRzo5vW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C37DA18-7584-4AD6-9979-9FE3EE4C7D10</gtr:id><gtr:title>HLA and outcome in living donor liver transplantation in primary biliary cirrhosis: a new piece in the jigsaw?</gtr:title><gtr:parentPublicationTitle>Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1527-6465</gtr:issn><gtr:outcomeId>EC34001D0C6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36993619-99C1-4479-B39E-A095212708B9</gtr:id><gtr:title>Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease.</gtr:title><gtr:parentPublicationTitle>Hepatology (Baltimore, Md.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2ac724aa0f3497723528e917e16d0a1"><gtr:id>a2ac724aa0f3497723528e917e16d0a1</gtr:id><gtr:otherNames>Syn WK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0270-9139</gtr:issn><gtr:outcomeId>gPYJeNRb9Rr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2905AE6-D260-48FD-9228-D4F07E7D76A5</gtr:id><gtr:title>The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids.</gtr:title><gtr:parentPublicationTitle>Gut</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec5ff98585e09ed0f4e5f845c5ababf2"><gtr:id>ec5ff98585e09ed0f4e5f845c5ababf2</gtr:id><gtr:otherNames>Forrest EH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0017-5749</gtr:issn><gtr:outcomeId>58A15BDBAE4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12F4FB18-0344-4C80-9BAE-9CE2F7C47B06</gtr:id><gtr:title>Persistent pyrexia post-liver transplantation: a unique case of pericardial tuberculosis.</gtr:title><gtr:parentPublicationTitle>European journal of internal medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/736816f8f545c53af3577861e58e44cd"><gtr:id>736816f8f545c53af3577861e58e44cd</gtr:id><gtr:otherNames>Oo YH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0953-6205</gtr:issn><gtr:outcomeId>404EC0D346F</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501638</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>